Gabriel Leung, Director at NovoCure Ltd (NVCR), sold 28,128 shares at $85.39 ($2.4M) on 2020-09-09, disclosed to the SEC on 2020-09-11.
Open-market sale of $2.4M NVCR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.39 | 9,014 | $770K | 31.4% |
| 2 | $85.39 | 9,014 | $770K | 31.4% |
| 3 | $86.06 | 100 | $9K | 0.4% |
| 4 | $90.00 | 10,000 | $900K | 36.8% |
| Total | $87.03 avg | 28,128 | $2.4M | 100% |
| Filing → |
| NVCR | SELL | 2024-06-06 | $23K | — | Filing → |
| NVCR | SELL | 2021-08-06 | $153K | — | Filing → |
| NVCR | SELL | 2021-07-08 | $184K | — | Filing → |